🇫🇷
France · FR · FR:61234861
BIVALIRUDINE ACCORD 250 mg, poudre pour solution à diluer pour solution injectable/pour perfusion
ATC B01AE06
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerACCORD HEALTHCARE FRANCE
CountryFR (France)
ATC codeB01AE06
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340095504868810 flacon(s) en verre de 10 ml
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "61234861",
"date_amm": "2018-01-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer injectable ou pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code B01AE06.
- CAANGIOMAXSANDOZ CANADA INCORPORATED
- FIAngioxOrifarm Oy
- FIAngioxThe Medicines Company UK Ltd
- BEAngiox 250 mgThe Medicines Company
- GBAngiox 250mg powder for concentrate for solution for infusion vialsThe Medicines Company UK Ltd
- 🇺🇸bivalirudinCivica, Inc.
- 🇺🇸bivalirudinSlate Run Pharmaceuticals, LLC
- 🇺🇸BivalirudinMAIA Pharmaceuticals, Inc.
Access this data programmatically
Query BIVALIRUDINE ACCORD 250 mg, poudre pour solution à diluer pour solution injectable/pour perfusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.